How have BDSX and GALT total returns compared?

Over the past 5 years, BDSX delivered -28.49% and GALT delivered 0.60% annualized total return. Past performance doesn't predict future results.

Biodesix, Inc. (BDSX) vs Galectin Therapeutics Inc. (GALT)

A side-by-side comparison of Biodesix, Inc. and Galectin Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BDSX

Biodesix, Inc.

$241M

$29.55HealthcareDelayed quote: Oct 6, 2026, 10:08 AM EDT

GALT

Galectin Therapeutics Inc.

$242M

$3.67HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT

Total return — BDSX vs GALT

growth of $100 · dividends reinvested · last 6y

BDSX -88.7% (-30.4%/yr)GALT +39.2% (+5.7%/yr)GALT compounded faster over this window

Log scale — wide-divergence pair

BDSX GALT

BDSX vs GALT: by the numbers

•GALT is the larger company ($242M vs $241M market cap).
•Both run net losses; GALT's is the smaller (0.00% vs -26.97% net margin).

Metrics side by side

Valuation

Metric	BDSX	GALT
P/S ratio	2.34	N/A
P/B ratio	26.30	N/A

Profitability

Metric	BDSX	GALT
Gross margin	82.50%	0.00%
Operating margin	-31.37%	0.00%
Net margin	-26.97%	0.00%
ROE	-303.61%	N/A
ROIC	-25.73%	-1718.59%

Growth (annualized)

Metric	BDSX	GALT
Revenue CAGR (5Y)	5.99%	N/A
Total return CAGR (5Y)	-28.49%	0.60%

Frequently asked

How have BDSX and GALT total returns compared?: Over the past 5 years, BDSX delivered -28.49% and GALT delivered 0.60% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BDSX analysis Full GALT analysis Interactive comparison tool

Dig into the metrics

Biodesix ROE Galectin Therapeutics ROE Biodesix operating margin Galectin Therapeutics operating margin Biodesix revenue growth Galectin Therapeutics revenue growth Biodesix free cash flow Galectin Therapeutics free cash flow

Biodesix & Galectin Therapeutics appear in these rankings

Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.